Last reviewed · How we verify
B: BI 10773 tablet and metformin tablet — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
B: BI 10773 tablet and metformin tablet (B: BI 10773 tablet and metformin tablet) — Boehringer Ingelheim.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| B: BI 10773 tablet and metformin tablet TARGET | B: BI 10773 tablet and metformin tablet | Boehringer Ingelheim | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- B: BI 10773 tablet and metformin tablet CI watch — RSS
- B: BI 10773 tablet and metformin tablet CI watch — Atom
- B: BI 10773 tablet and metformin tablet CI watch — JSON
- B: BI 10773 tablet and metformin tablet alone — RSS
Cite this brief
Drug Landscape (2026). B: BI 10773 tablet and metformin tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/b-bi-10773-tablet-and-metformin-tablet. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab